journal article·2025-03Open access

Hydrogen bonding in the crystal structure of molnupiravir Form I, C 13 H 19 N 3 O 7

Tawnee M. Ens, James A. Kaduk, Megan M. Rost, Anja Dosen, Thomas N. Blanton

Powder Diffraction· Volume 40· Issue 1

Abstract

Molnupiravir Form I crystallizes in space group C 2 (#5) with a = 6.48110(17), b = 8.71848(19), c = 27.0607(19) Å, β = 91.920(4)°, V = 1528.22(12) Å 3 , and Z = 4 at 295 K. The crystal structure consists of supramolecular double layers of molecules parallel to the ab -plane. The layer centers consist of hydrogen-bonded rings forming a 2D network and the outer surfaces of isopropyl groups, with van der Waals interactions between the layers. Each O atom acts as an acceptor in at least one hydrogen bond. A strong O–H⋯O hydrogen bond forms between the hydroxyl group of the oxolane ring and the carbonyl group of the oxopyrimidine ring. The other oxolane hydroxyl group forms bifurcated intra- and intermolecular hydrogen bonds. The hydroxylamino group forms an intramolecular O–H⋯N hydrogen bond with an N atom of the oxopyrimidine ring. The amino group forms an intermolecular N–H⋯N hydrogen bond to the same N atom of the ring. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File™ (PDF®).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Veterinary medicine and infectious diseases · X-ray Diffraction in Crystallography

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (32)

Show source-provided references
1. Developing a Direct Acting, Orally Available Antiviral Agent in a Pandemic: The Evolution of Molnupiravir as a Potential Treatment for COVID-1910.1016/j.coviro.2021.06.003 ↗
2. Validation of Molecular Crystal Structures from Powder Diffraction Data with Dispersion-Corrected Density Functional Theory (DFT-D)10.1107/S2052520614022902 ↗
3. Crystal Structures of Alkali Metal (Group 1) Citrate Salts10.1107/S2052520618002330 ↗
4. Polymorphs, Particle Size, and a Pandemic: Development of a Scalable Crystallization Process for Molnupiravir, an Antiviral for the Treatment of COVID-1910.1021/acs.oprd.3c00268 ↗
5. Etudes sur la loi de Bravais10.3406/bulmi.1907.2820 ↗
6. Discovery, Development, and Patent Trends on Mulnupiravir; A Propective Oral Treatment for COVID-1910.3390/molecules26195795 ↗
7. Crystalexplorer: A Program for Hirshfeld Surface Analysis, Visualization and Quantitative Analysis of Molecular Crystals
8. Polymorphs and Solvates of Molnupiravir: Crystal Structures and Solid Forms Transformation Analysis10.1021/acs.cgd.4c00376 ↗
9. A Twelve-Analyzer Detector System for High-Resolution Powder Diffraction10.1107/S0909049508018438 ↗
10. Xuchun, Z. , Yiping, Z. , and Chenchen, F. . 2021. “Molnupiravir Crystal Form A and Preparation Method Thereof.” Chinese Patent CN112778387 A.
11. Phase 2/3 Trial of Molnupiravir for Treatment of COVID-19 in Nonhospitalized Adults10.1056/EVIDoa2100043 ↗
12. CRYSTAL23: A Program for Computational Solid State Physics and Chemistry10.1021/acs.jctc.2c00958 ↗
13. Retrieval of Crystallographically-Derived Molecular Geometry Information10.1021/ci049780b ↗
14. Bravais · 1866
15. 2023
16. Efficiency of Ab-Initio Total Energy Calculations for Metals and Semiconductors Using a Plane-Wave Basis Set10.1016/0927-0256(96)00008-0 ↗
17. Crystal-Field Effects on the Topological Properties of the Electron-Density in Molecular Crystals: The Case of Urea10.1063/1.467882 ↗
18. Molnupiravir in COVID-19: A Systematic Review of Literature10.1016/j.dsx.2021.102329 ↗
19. State-of-the-Art High-Resolution Powder X-Ray Diffraction (HRPXRD) Illustrated with Rietveld Refinement of Quartz, Sodalite, Tremolite, and Meionite10.3749/canmin.46.5.1501 ↗
20. Crystal Structure of Atomoxetine Hydrochloride (Strattera), C17H22NOCl10.1017/S0885715614000517 ↗
21. Bonded-Atom Fragments for Describing Molecular Charge Densities10.1007/BF00549096 ↗
22. GSAS II: The Genesis of a Modern Open Source All Purpose Crystallography Software Package10.1107/S0021889813003531 ↗
23. Bothe, J. R. , Brunskill, A. P. J. , Lockwood, M. , Newman, J. A. , and Saindane, M. T. . 2022. “Novel Forms of Antiviral Nucleosides.” International Patent Application WO 2022/047229 A1.
24. New Software for Statistical Analysis of Cambridge Structural Database Data10.1107/S0021889811014622 ↗
25. A Dedicated Powder Diffraction Beamline at the Advanced Photon Source: Commissioning and Early Operational Results10.1063/1.2969260 ↗
26. FOX, Free Objects for Crystallography: A Modular Approach to Ab Initio Structure Determination from Powder Diffraction10.1107/S0021889802015236 ↗
27. 2023
28. Mercury 4.0: From Visualization to Design and Prediction10.1107/S1600576719014092 ↗
29. PDF-5+: A Comprehensive Powder Diffraction File™ for Materials Characterization10.1017/S0885715624000150 ↗
30. A New Law of Crystal Morphology Extending the Law of Bravais
31. Cavazzoni, P. A. 2023. “Molnupiravir Emergency Use Authorization 108.” www.fda.gov/media/155053/download.
32. 2023